Find Out if the Oncotype DX Test Can Help Personalize Your Treatment

The Oncotype DX breast cancer tests are genomic tests that may help guide treatment decisions for patients with early-stage breast cancer: non-invasive breast cancer, often referred to as ductal carcinoma in situ (DCIS), and help early-stage invasive breast cancer patients with estrogen receptor-positive (ER+) disease evaluate if they will benefit from chemotherapy.

Please take the quick quiz below to help you determine whether the Oncotype DX test may be appropriate for you:

Are you a newly diagnosed breast cancer patient or caregiver trying to determine what treatment plan is right for you or a loved one?